SPONSOR
Yizhuo Zhang
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Pediatric Solid Tumor, Unspecified, Protocol SpecificRhabdomyosarcomaPediatric Cancer
Yizhuo Zhang is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Pediatric Solid Tumor, Unspecified, Protocol Specific, Rhabdomyosarcoma, Pediatric Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yizhuo Zhang
How many clinical trials has Yizhuo Zhang sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Yizhuo Zhang, of which 2 are actively recruiting participants. These trials cover conditions including Pediatric Solid Tumor, Unspecified, Protocol Specific, Rhabdomyosarcoma, Pediatric Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yizhuo Zhang research focus on?
Yizhuo Zhang clinical trials span Pediatric Solid Tumor, Unspecified, Protocol Specific, Rhabdomyosarcoma, Pediatric Cancer. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Yizhuo Zhang clinical trial?
To participate in a Yizhuo Zhang trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yizhuo Zhang trials with current recruitment status updated daily.
Clinical Trials by Yizhuo Zhang
NCT06208917 Phase 3
Recruiting
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Pediatric Solid Tumor, Unspecified, Protocol Specific
NCT06836492 Phase 3
Recruiting
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Rhabdomyosarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology